Just as death and serious illness are both medical and mystical events, so too must be our methods of addressing them.

In order to pursue a deep sense of tranquility in the face of mortality and suffering, for some people, practices such as mindfulness, breathwork, qigong, and spiritual pursuits might be adequate. However, for others, the toolbox needs to be broader.

In some settings, psilocybin and ketamine are emerging as potential tools in part because of how they connect us to our bodies, nature, and mystical experiences.

While researchers are pursuing more rigorous clinical trials, we don’t want to wait around as people suffer unnecessarily. Our mission is to create a container that is safe, legal, and science-based, as we await research consensus.

Clinically, when used in a supervised therapeutic setting, psilocybin has been shown to be an effective treatment for cancer-related anxiety. It may be effective therapeutically because it amplifies and enlivens the psychically agitating material that perpetuates suffering. In doing so, the psychedelic amplification can offer an opportunity to expand one’s relationship to these difficulties and diffuse their charge, bringing about enduring relief and growth.

Worldwide, there are hundreds of ongoing research projects into the medical applications of psychedelics, and this number grows every year.  There is already substantial evidence that psychedelics such as psilocybin and ketamine can alleviate or reduce anxiety, depression, PTSD, and fear approaching the end of life. To make the most of this current moment in history, the cancer community needs leadership that values data, human rights, science, legality, and compassion.

That’s where we come in.

Contact Us